ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Pneumocandin C(0)
C50H80N8O17
1065.2 g/mol
API

Pneumocandin C(0)

CAS144074-96-4
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Pneumocandin C(0) is a cyclic hexapeptide compound used as an active pharmaceutical ingredient impurity. It is characterized by a complex macrocyclic structure with multiple hydroxyl, amide, and aromatic functional groups, and is primarily encountered in pharmaceutical manufacturing and quality control contexts.

reference standard for pharmaceutical impurity testingresearch compound for analytical method development

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Pneumocandin C(0)?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.91

Pneumocandin B0

CAS135575-42-7

pharmaceutical raw material

ReferenceSame Category

Vebreltinib

CAS1440964-89-5

pharmaceutical raw material

ReferenceSame Category

Ledipasvir acetone

CAS1441674-54-9

pharmaceutical raw material

ReferenceSame Category

Ripretinib

CAS1442472-39-0

pharmaceutical raw material

ReferenceSame Category

2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-7-oxido-9H-purin-9-yl]-, (1S,4R)-

CAS1443421-70-2

pharmaceutical raw material

Referencesame scaffold

Caspofungin

CAS162808-62-0

pharmaceutical raw material

Referencesame scaffold

Caspofungin acetate

CAS179463-17-3

pharmaceutical raw material

Referencesame scaffold

FR 901379

CAS144371-88-0

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

N-[(3S,6S,9S,11R,15S,20S,21R,24S,26R)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-6-[(2R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,26-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide

InChIKey

IPMHTGKXJQHTQV-YWVCOZMLSA-N

SMILES

CCC(C)CC(C)CCCCCCCCC(=O)NC1C[C@@H]([C@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)C([C@@H](C4=CC=C(C=C4)O)O)O)[C@@H](CC(=O)N)O)O)O)O

Synonyms (5)
  • Pneumocandin C(0)
  • Pneumocandin Co

Sourcing Pneumocandin C(0)?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→